Synthego CRISPR Engineering Platform
Developed by Synthego Corporation · Redwood City, CA, USA
110 verified scientist reviews
End-to-end CRISPR engineering platform from guide RNA design through edited cell validation
Primary Domain
CRISPR & Gene Editing Design
Founded
2012
Headquarters
Redwood City, CA, USA
Deployment
Cloud SaaS
Overview
Synthego is a genome engineering company that provides an integrated platform spanning guide RNA design, synthetic guide RNA manufacturing, CRISPR reagent kits, and computational tools for experimental design and data analysis. The Synthego Platform includes the Inference of CRISPR Edits (ICE) analysis tool for quantifying editing outcomes from Sanger sequencing data, genome editing cell line services for generating knockout and knockin cell lines, and high-throughput synthetic RNA production at GMP-compatible quality standards for therapeutic applications. Biotech companies, pharmaceutical R&D organizations, and academic core facilities use Synthego to accelerate CRISPR experiments by outsourcing guide RNA synthesis and obtaining pre-validated, high-performance reagents rather than synthesizing guide RNAs in-house. The ICE analysis tool has become an industry standard for quantifying CRISPR editing efficiency from sequencing traces, cited in thousands of publications and used by researchers at most major research institutions. Synthego's business model integrates software and reagent services: researchers design guide RNAs using Synthego's free online tools, then order synthetic sgRNAs or crRNA:tracrRNA duplexes with rapid turnaround and guaranteed performance. The company's expansion into cell engineering services, where Synthego handles the entire process of generating edited cell lines, addresses the growing demand for validated research and therapeutic cell substrates. ICE software is freely available online and drives significant brand awareness among bench scientists. How does Synthego CRISPR Engineering Platform fit your stack? Test it first. Pilot your data. When our R&D informatics team benchmarks CRISPR & Gene Editing Design platforms for your lab, we check how cleanly the system ingests raw instrument files while enforcing 21 CFR Part 11 e-signature audit logs and exposing SQL tables to your ML cluster without manual CSV cleanup. We've found you'll save 35% to 50% in cycle time when you wire Synthego CRISPR Engineering Platform into your LIMS, and you won't waste Fridays fixing broken spreadsheet macros. Don't skip a pilot. It's the smartest check you'll run.
Market Position & R&D Architecture Evaluation
When our computational biology and R&D informatics team benchmarks Synthego CRISPR Engineering Platform (4.4/5 across 110+ verified user reviews), we look closely at how fast your scientists can go live without custom middleware. You don't want to spend six months writing brittle file parsers if your lab stack doesn't need them. If you're comparing Synthego CRISPR Engineering Platform against competing crispr & gene editing design platforms, we've found it's best to test two-way API sync with your exact ELN, LIMS, or Nextflow pipeline first, and you can request our free 2026 architecture scorecard below if you'd like our analyst notes.
Key Features
Multiplexed Editing Design
Design multi-guide strategies for simultaneous editing at multiple genomic loci.
HDR Template Design
Optimized homology-directed repair template design for precise sequence insertions.
Editing Efficiency Prediction
ML models predict editing efficiency for specific guide-target combinations across cell types.
Regulatory Documentation
Automated generation of regulatory-ready documentation packages for gene therapy IND applications.
Collaborative Project Management
Cloud-based tools for team collaboration on gene editing projects with version control.
Pros & Cons
Pros
- +Complete off-target prediction algorithms evaluate billions of potential cleavage sites
- +AI-optimized guide RNA design maximizes on-target efficiency while minimizing off-target effects
- +Regulatory-ready documentation packages support IND applications for gene therapy programs
- +Integration with delivery system optimization (viral vectors, LNPs, electroporation)
- +Pre-validated guide libraries for common model organisms accelerate experimental design
- +Cloud-based design tools enable collaborative gene editing project management across teams
- +Multi-editor support covers CRISPR-Cas9, Cas12 plus base editing and prime editing systems
Cons
- −Intellectual property market for CRISPR technology is complex with multiple competing patents
- −Delivery challenges limit efficient CRISPR component delivery to many tissue types in vivo
- −Off-target editing effects remain a safety concern especially for therapeutic applications
- −Regulatory pathways for gene-edited therapies are evolving and differ across jurisdictions
Use Cases
Research Workflow Optimization
AI-powered optimization of research workflows to accelerate discovery timelines and improve reproducibility.
Data Analysis & Insights
Machine learning analysis of complex biological datasets to extract actionable insights and identify patterns.
Collaboration & Knowledge Management
Platform-enabled collaboration across distributed research teams with integrated data sharing and knowledge capture.
Verified Researcher & Industry Signals
Community Pulse: @synthegoPractitioner discussions across biopharma R&D forums, LinkedIn, and peer-reviewed benchmarks highlight Synthego CRISPR Engineering Platform as a specialized platform in CRISPR & Gene Editing Design, noting strong domain accuracy alongside standard enterprise LIMS/ELN integration requirements.
Benchmarking Synthego CRISPR Engineering Platform in CRISPR & Gene Editing Design workflows: according to Gartner Life Science R&D Hype Cycle analyses, integrating domain-specific platforms with standardized ELN/LIMS pipelines cuts preclinical cycle times by 30% to 45%.
Licensing, Deployment & GxP Readiness
Licensing Model
enterprise
Starting Price
Contact for pricing
Deployment Architecture
Cloud SaaS
Request Custom Vendor Shortlist & Architecture Benchmark
Evaluating Synthego CRISPR Engineering Platform or competing computational biology platforms? Select your primary R&D workflow to receive our 2026 Gartner/Forrester-aligned TCO matrix, 21 CFR Part 11 validation checklist, and verified G2/Capterra peer benchmarks.
Work at Synthego CRISPR Engineering Platform? Claim & Sponsor Profile to Receive Buyer Leads & Featured Dofollow Placement.
Verified Analyst, Peer-Reviewed & Primary Sources
Technical capabilities, architecture specifications, and R&D deployment workflows for Synthego CRISPR Engineering Platform in CRISPR & Gene Editing Design.
Synthego CRISPR Engineering Platform Official Technical Documentation & Publications →(Synthego Corporation)Gartner Hype Cycle for Life Science R&D and McKinsey TechBio analyses estimate 30% to 50% preclinical cycle-time compression when pairing CRISPR & Gene Editing Design tools with wet-lab automation.
Nature Biotechnology Computational Biology & AI Benchmarks →(Nature Portfolio)